TCRT Alaunos Therapeutics, Inc. - Common Stock
$1,93
Cena · Sie 17, 2026
Dane fundamentalne na dzień Sie 14, 2026
Zakres 52 tyg.
$2–$5
9% of range
Ocena Analityków
HOLD
6 analysts
Cena Docelowa
—
P/E (TTM)
-1.5
ROE
—
Marża Zysku Netto
—
O Alaunos Therapeutics, Inc. - Common Stock Przegląd firmy z Wikipedii
TCRT Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$1.93
Kapitalizacja Rynkowa
—
P/E (TTM)
-1.5
EPS (TTM)
$-2.20
Przychody (TTM)
$5.0K
Stopa dywidendy
—
ROE
—
D/E Dług/Kapitał
—
Zakres 52 tyg.
$2 – $5
TCRT Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$5.0K
2017-12-31
→
2025-12-31
EPS
$-2.20
2016-12-31
→
2025-12-31
Wolny przepływ pieniężny
—
2016-12-31
→
2023-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
TCRT
Mediana porównawcza
P/E (TTM)
-1.5
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
TCRT
Mediana porównawcza
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
TCRT
Mediana porównawcza
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
TCRT
Mediana porównawcza
Revenue YoY (Przychody R/R)
-50.0%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-88.0%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
TCRT
Mediana porównawcza
TCRT Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
SPRZEDAJ
6 analityków
- Mocne kupno 0 0,0%
- Kup 0 0,0%
- Trzymaj 3 50,0%
- Sprzedaj 1 16,7%
- Mocna sprzedaż 2 33,3%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.04%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 grudnia 2023 | $-4.90 | $-4.59 | -0.31% |
| 30 września 2023 | $-6.00 | $-5.36 | -0.65% |
| 30 czerwca 2023 | $-6.00 | $-6.73 | 0.73% |
| 31 marca 2023 | $-6.00 | $-6.38 | 0.38% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| TCRT | — | -1.5 | -50.0% | — | — | — |
| GOVX | $296.2K | — | -37.1% | -862.3% | -645.9% | — |
| LABT | — | — | — | — | — | — |
| BCAB | — | -0.6 | — | — | — | — |
| MBIO | — | -2.5 | — | — | -30.9% | — |
| APVO | $9M | -0.1 | — | — | -217.2% | — |
| MBRX | — | — | — | — | — | — |
| HCWB | — | -0.1 | -97.9% | -14677.1% | -586.8% | 20.0% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.0K | $10.0K | $5.0K | $3M | $398.0K | $0 | · | $146.0K | $16M | · | · | · | |
| R&D Expense | $1M | $362.0K | $16M | $25M | $50M | $53M | $38M | $34M | $45M | $158M | $107M | $33M | |
| SG&A Expense | $3M | $4M | $12M | $13M | $28M | $28M | $20M | $20M | $15M | $14M | $18M | $12M | |
| Operating Expenses | $4M | $5M | $34M | $38M | $78M | $80M | $58M | $54M | $60M | · | · | · | |
| Operating Income | $-4M | $-5M | $-34M | $-35M | $-78M | $-80M | $-58M | $-54M | $-53M | $-165M | $-120M | $-43M | |
| Interest Expense | · | · | $2M | $3M | $1M | · | · | · | · | · | · | · | |
| Other Non-op | $80.0K | $133.0K | $1M | $529.0K | $-13.0K | $385.0K | $813.0K | $631.0K | $465.0K | $134.0K | $12.0K | $-5.0K | |
| Income Tax | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-4M | $-5M | $-5M | $-38M | $-79M | $-80M | $-118M | $-53M | $-54M | $-165M | $-120M | $-32M | |
| EPS (Basic) | $-2.20 | $-2.92 | $-21.97 | $-2.61 | $-0.37 | $-0.38 | $-0.70 | $0.96 | $-0.53 | $-1.32 | · | · | |
| EPS (Diluted) | $-2.20 | $-2.92 | $-21.97 | $-2.61 | $-0.37 | $-0.38 | $-0.70 | $0.96 | $-0.53 | $-1.32 | · | · | |
| Shares (Basic) | 1,948,357 | 1,601,252 | 1,599,532 | 14,475,354 | 214,399,074 | 209,636,456 | 167,952,114 | 143,508,674 | 136,938,264 | 130,391,463 | · | · | |
| Shares (Diluted) | 1,948,357 | 1,601,252 | 1,599,532 | 14,475,354 | 214,399,074 | 209,636,456 | 167,952,114 | 143,710,160 | 136,938,264 | 130,391,463 | · | · | |
| EBITDA | · | · | $-34M | $-35M | $-78M | $-80M | · | $-54M | · | $-165M | $-120M | $-43M |
Bilans 22
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $1M | $6M | $39M | $76M | $115M | $80M | $62M | $71M | $81M | $141M | $43M | |
| Receivables | $3.0K | $5.0K | $1.0K | $4.0K | $1M | $5M | $3M | $2M | $19.0K | $21.0K | $446.0K | $145.0K | |
| Prepaid Expense | $600.0K | $2M | $2M | $799.0K | $2M | $11M | $22M | $21M | $20M | $24M | $11M | $1M | |
| Current Assets | $2M | $3M | $8M | $54M | $79M | $131M | $105M | $84M | $91M | $105M | $153M | $44M | |
| PP&E (Net) | $91.0K | $0 | $2.0K | $8M | $11M | $10M | $1M | $1M | $1M | $843.0K | $581.0K | $531.0K | |
| PP&E (Gross) | $98.0K | $15.0K | $15.0K | $18M | $18M | $15M | $6M | $5M | $5M | $4M | $4M | $3M | |
| Accum. Depreciation | $7.0K | $15.0K | $13.0K | $10M | $7M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | |
| Other Non-current Assets | · | · | $0 | $500.0K | $631.0K | $745.0K | $110.0K | $10M | $13M | $493.0K | $494.0K | $491.0K | |
| Total Assets | $3M | $3M | $8M | $65M | $95M | $146M | $109M | $95M | $106M | $106M | $154M | $45M | |
| Accounts Payable | $613.0K | $516.0K | $616.0K | $1M | $1M | $960.0K | $906.0K | $707.0K | $4M | $156.0K | $2M | $2M | |
| Accrued Liabilities | $200.0K | $176.0K | $1M | $5M | $6M | $17M | $11M | $9M | $10M | $9M | $9M | $7M | |
| Current Liabilities | $813.0K | $692.0K | $2M | $24M | $16M | $18M | $13M | $9M | $21M | $16M | $18M | $11M | |
| Capital Leases | · | · | · | · | · | $4M | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | $0 | $28.0K | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $813.0K | $692.0K | $2M | $26M | $37M | $22M | $14M | $9M | $58M | $58M | $66M | $11M | |
| Long-term Debt | · | · | $0 | $17M | $24M | $0 | · | · | · | · | · | · | |
| Total Debt | · | · | $0 | $17M | $24M | · | · | · | · | · | · | · | |
| Common Stock | $2.0K | $2.0K | $2.0K | $16.0K | $216.0K | $215.0K | $182.0K | $161.0K | $143.0K | $132.0K | $132.0K | $104.0K | |
| Retained Earnings | $-925M | $-920M | $-916M | $-881M | $-843M | $-764M | $-684M | $-566M | $-712M | $-658M | $-493M | $-373M | |
| Stockholders' Equity | $2M | $2M | $6M | $39M | $58M | $124M | $95M | $86M | $-97M | $-77M | $87M | $34M | |
| Liabilities + Equity | $3M | $3M | $8M | $65M | $95M | $146M | $109M | $95M | $106M | $106M | $154M | $45M | |
| Shares Outstanding | 2,349,480 | 1,601,252 | 1,601,252 | 16,027,384 | 216,127,443 | 214,591,906 | 181,803,320 | 161,066,136 | 142,658,037 | 132,376,670 | 131,718,579 | 104,452,105 |
Przepływy pieniężne 15
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | $290.0K | $357.0K | $462.0K | |
| Stock-based Comp | $796.0K | $435.0K | $3M | $4M | $11M | $7M | $6M | $8M | $8M | $8M | $8M | $5M | |
| Restructuring | · | $0 | $1M | $0 | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-5M | $-30M | $-29M | $-61M | $-57M | $-41M | $-49M | $-55M | $-58M | $-10.0K | $-37M | |
| CapEx | $98.0K | $0 | $197.0K | $216.0K | $3M | $10M | $284.0K | $459.0K | $737.0K | $551.0K | $412.0K | $193.0K | |
| Investing Cash Flow | $-98.0K | $0 | $1M | $-193.0K | $-3M | $-10M | $-284.0K | $-459.0K | $-737.0K | $-551.0K | · | · | |
| Debt Issued | · | · | · | $0 | $25M | $0 | · | · | · | · | · | · | |
| Net Debt Issued | · | · | $-18M | $-8M | $25M | · | · | · | · | · | · | · | |
| Stock Issued | · | $0 | $92.0K | $15M | $0 | · | · | · | $47M | · | $94M | · | |
| Stock Repurchased | · | · | $0 | $45.0K | $0 | · | $653.0K | $2M | $0 | $2.0K | $34.0K | $544.0K | |
| Net Stock Activity | · | · | $92.0K | $15M | · | · | · | $-2M | · | $-2.0K | $94M | $-544.0K | |
| Financing Cash Flow | $3M | $0 | $-18M | $6M | $26M | $102M | $59M | $40M | $45M | $-788.0K | · | · | |
| Net Change in Cash | $294.0K | $-5M | $-47M | $-23M | $-39M | $35M | $18M | $-10M | $-10M | $-60M | $98M | $-25M | |
| Taxes Paid | · | · | · | · | · | · | · | $0 | $0 | $0 | · | · | |
| Free Cash Flow | · | · | $-30M | $-29M | $-65M | $-67M | · | $-50M | · | $-59M | $-422.0K | $-37M |
Rentowność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -685340.0% | -1201.4% | -19484.7% | · | · | · | · | · | · | · | |
| Net Margin | · | · | -702800.0% | -1291.2% | -19786.7% | · | · | · | · | · | · | · | |
| EBITDA Margin | · | · | -685340.0% | -1201.4% | -19484.7% | · | · | · | · | · | · | · | |
| ROA | · | · | -96.0% | -47.2% | -65.3% | -62.6% | · | -52.9% | · | -127.1% | -120.7% | -54.3% | |
| ROE | · | · | -347.8% | -106.8% | -124.2% | -59.5% | · | 149.9% | · | -3282.0% | -198.2% | -76.4% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | 4.2 | 2.2 | 4.9 | 7.1 | · | 8.9 | · | 6.6 | 8.4 | 4.1 | |
| Quick Ratio | · | · | 3.1 | 1.6 | 4.8 | 6.5 | · | 6.7 | · | 5.1 | 7.8 | 4.0 | |
| Debt / Equity | · | · | 0.0 | 0.4 | 0.4 | · | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | 0.0 | 0.0 | 0.3 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | -17.8 | -11.1 | · | · | · | · | · | · | · | · |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Receivables Turnover | · | · | 2.0 | 5.2 | 0.1 | · | · | · | · | · | · | · |
Stopy Wzrostu 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -50.0% | 100.0% | -99.8% | 634.2% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -88.0% | -70.7% | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.0K | $10.0K | $5.0K | $3M | $398.0K | $0 | · | $146.0K | $16M | $800.0K | $800.0K | $800.0K | |
| Net Income TTM | $-4M | $-5M | $-5M | $-38M | $-79M | $-80M | $-118M | $-53M | $-54M | $-165M | $-120M | $-32M | |
| Market Cap | · | · | $168M | $23.44B | $35.34B | $81.12B | · | $45.18B | · | $106.23B | $164.19B | $79.44B | |
| Enterprise Value | · | · | $162M | $23.42B | $35.28B | · | · | · | · | · | · | · | |
| P/E | -1.5 | -0.7 | -0.5 | -37.4 | -441.9 | -994.7 | -1011.4 | 292.2 | -1171.7 | -608.0 | · | · | |
| P/S | · | · | 33626.3 | 8021.9 | 88786.0 | · | · | 309445.6 | · | 132790.3 | 205234.0 | 99294.8 | |
| P/B | · | · | 26.7 | 608.0 | 608.7 | 654.3 | · | 528.0 | · | -1374.3 | 1879.2 | 2347.3 | |
| P / Tangible Book | 3.5 | 1.5 | 26.7 | 608.0 | 608.7 | 654.3 | · | · | · | · | · | · | |
| P / Cash Flow | · | · | -5.6 | -801.9 | -574.9 | -1422.8 | · | -913.5 | · | -1821.4 | -16418720.9 | -2167.4 | |
| P / FCF | · | · | -5.5 | -796.0 | -545.4 | -1214.5 | · | -905.1 | · | -1804.3 | -389069.2 | -2156.1 | |
| EV / EBITDA | · | · | -4.7 | -667.1 | -455.0 | · | · | · | · | · | · | · | |
| EV / FCF | · | · | -5.3 | -795.2 | -544.6 | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | 32413.9 | 8014.3 | 88655.5 | · | · | · | · | · | · | · | |
| Earnings Yield | -68.1% | -152.9% | -209.2% | -2.7% | -0.23% | -0.10% | -0.10% | 0.34% | -0.09% | -0.16% | · | · |
Rachunek zysków i strat 13
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $3.0K | $0 | $0 | $2.0K | $5.0K | $0 | $4.0K | $1.0K | $0 | $4.0K | $0 | $11.0K | $3M | $0 | |
| R&D Expense | $388.0K | $427.0K | $362.0K | $469.0K | $185.0K | $347.0K | $-87.0K | $143.0K | $180.0K | $126.0K | $4M | $5M | $7M | $6M | $8M | $6M | |
| SG&A Expense | $564.0K | $585.0K | $548.0K | $718.0K | $854.0K | $747.0K | $846.0K | $1M | $990.0K | $2M | $4M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $952.0K | $1M | $910.0K | $1M | $1M | $1M | $759.0K | $1M | $1M | $2M | $9M | $8M | $10M | $9M | $11M | $9M | |
| Operating Income | $-952.0K | $-1M | $-907.0K | $-1M | $-1M | $-1M | $-754.0K | $-1M | $-1M | $-2M | $-9M | $-8M | $-10M | $-9M | $-8M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $1M | $853.0K | $890.0K | $841.0K | $740.0K | |
| Other Non-op | $0 | $6.0K | $14.0K | $28.0K | $19.0K | $19.0K | $13.0K | $23.0K | $37.0K | $60.0K | $188.0K | $277.0K | $477.0K | $254.0K | $254.0K | $41.0K | |
| Net Income | $-952.0K | $-1M | $-893.0K | $-1M | $-1M | $-1M | $-741.0K | $-1M | $-1M | $-2M | $-8M | $-9M | $-10M | $-9M | $-9M | $-10M | |
| EPS (Basic) | $-0.41 | $-0.59 | $-0.35 | $-0.55 | $-0.63 | $-0.67 | $-0.46 | $-0.70 | $-0.71 | $-1.05 | $-5.30 | $-5.49 | $-0.63 | $-2.47 | $-0.04 | $-0.05 | |
| EPS (Diluted) | $-0.41 | $-0.59 | $-0.35 | $-0.55 | $-0.63 | $-0.67 | $-0.46 | $-0.70 | $-0.71 | $-1.05 | $-5.30 | $-5.49 | $-0.63 | $-2.47 | $-0.04 | $-0.05 | |
| Shares (Basic) | 2,431,695 | 1,948,357 | -3,512,279 | 2,183,039 | 1,676,345 | 1,601,252 | -3,201,558 | 1,601,252 | 1,600,306 | 1,601,252 | 1,600,306 | 1,598,650 | 15,978,623 | -630,569,103 | 215,098,995 | 214,998,893 | |
| Shares (Diluted) | 2,431,695 | 1,948,357 | -3,512,279 | 2,183,039 | 1,676,345 | 1,601,252 | -3,201,558 | 1,601,252 | 1,600,306 | 1,601,252 | 1,600,306 | 1,598,650 | 15,978,623 | -630,569,103 | 215,098,995 | 214,998,893 | |
| EBITDA | $-952.0K | $-1M | · | $-1M | $-1M | $-1M | · | $-1M | $-1M | $-2M | $-9M | $-8M | $-10M | · | $-8M | $-9M |
Bilans 21
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $124.0K | $354.0K | $1M | $2M | $3M | $319.0K | $1M | $2M | $2M | $4M | $12M | $18M | $23M | $39M | $38M | $60M | |
| Receivables | $0 | $0 | $3.0K | $0 | $2.0K | $2.0K | $5.0K | $0 | $4.0K | $1.0K | $0 | $4.0K | $0 | $4.0K | $3M | $0 | |
| Prepaid Expense | $542.0K | $616.0K | $600.0K | $747.0K | $857.0K | $746.0K | $2M | $2M | $2M | $2M | $925.0K | $457.0K | $750.0K | $799.0K | $849.0K | $1M | |
| Current Assets | $666.0K | $970.0K | $2M | $3M | $4M | $1M | $3M | $4M | $5M | $6M | $13M | $19M | $38M | $54M | $56M | $61M | |
| PP&E (Net) | $74.0K | $82.0K | $91.0K | $97.0K | · | · | $0 | $0 | $0 | $0 | $6M | $7M | $8M | $8M | $9M | $10M | |
| PP&E (Gross) | · | · | $98.0K | · | · | · | $15.0K | · | · | · | · | · | · | $18M | · | · | |
| Accum. Depreciation | · | · | $7.0K | · | · | · | $15.0K | · | · | · | · | · | · | $10M | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | $0 | $500.0K | $500.0K | $500.0K | $500.0K | $500.0K | |
| Total Assets | $2M | $2M | $3M | $4M | $5M | $2M | $3M | $4M | $5M | $6M | $19M | $28M | $49M | $65M | $67M | $74M | |
| Accounts Payable | $732.0K | $400.0K | $613.0K | $843.0K | $809.0K | $831.0K | $516.0K | $458.0K | $365.0K | $597.0K | $1M | $1M | $1M | $1M | $2M | $474.0K | |
| Accrued Liabilities | $132.0K | $195.0K | $200.0K | $78.0K | $265.0K | $231.0K | $176.0K | $368.0K | $542.0K | $643.0K | $3M | $3M | $4M | $5M | $8M | $6M | |
| Current Liabilities | $864.0K | $595.0K | $813.0K | $921.0K | $1M | $1M | $692.0K | $826.0K | $907.0K | $1M | $5M | $5M | $17M | $24M | $33M | $27M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $28.0K | $28.0K | $28.0K | $28.0K | |
| Total Liabilities | $864.0K | $595.0K | $813.0K | $921.0K | $1M | $1M | $692.0K | $826.0K | $907.0K | $1M | $6M | $6M | $19M | $26M | $35M | $34M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $17M | $23M | $25M | |
| Total Debt | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $11M | · | $23M | $25M | |
| Common Stock | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $16.0K | $241.0K | $241.0K | $241.0K | $16.0K | $216.0K | $216.0K | |
| Retained Earnings | $-927M | $-926M | $-925M | $-924M | $-923M | $-922M | $-920M | $-920M | $-919M | $-917M | $-908M | $-899M | $-891M | $-881M | $-871M | $-863M | |
| Stockholders' Equity | $652.0K | $1M | $2M | $3M | $4M | $1M | $2M | $3M | $4M | $5M | $14M | $22M | $30M | $39M | $32M | $40M | |
| Liabilities + Equity | $2M | $2M | $3M | $4M | $5M | $2M | $3M | $4M | $5M | $6M | $19M | $28M | $49M | $65M | $67M | $74M | |
| Shares Outstanding | 2,486,140 | 2,378,383 | 2,349,480 | 2,205,846 | 2,074,746 | 1,601,252 | 1,601,252 | 1,601,252 | 1,601,252 | 16,012,522 | 240,627,055 | 240,627,055 | 240,627,055 | 16,027,384 | 216,182,042 | 216,174,542 |
Przepływy pieniężne 12
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $246.0K | $141.0K | $243.0K | $301.0K | $184.0K | $68.0K | $82.0K | $80.0K | $101.0K | $172.0K | $726.0K | $914.0K | $910.0K | $877.0K | $808.0K | $990.0K | |
| Restructuring | · | · | · | · | · | · | · | $0 | · | · | $419.0K | · | · | $0 | $0 | · | |
| Operating Cash Flow | $-300.0K | $-1M | $-552.0K | $-844.0K | $-701.0K | $-772.0K | $-592.0K | $-781.0K | $-2M | $-2M | $-6M | $-7M | $-9M | $-7M | $-6M | $-8M | |
| CapEx | · | · | $1.0K | · | · | · | $0 | $0 | $0 | $0 | $1.0K | $135.0K | $61.0K | $116.0K | $14.0K | $57.0K | |
| Investing Cash Flow | · | · | $-1.0K | · | · | · | $0 | $0 | $0 | $0 | $1.0K | $-135.0K | $-23.0K | $-93.0K | $-14.0K | $-57.0K | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | $-6M | · | · | · | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $92.0K | $15M | $0 | $0 | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | $92.0K | · | · | · | |
| Financing Cash Flow | · | · | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $-12M | $-6M | $8M | $-2M | $0 | |
| Net Change in Cash | $-230.0K | $-1M | $-553.0K | $-941.0K | $3M | $-772.0K | $-592.0K | $-781.0K | $-2M | $-2M | $-6M | $-19M | $-16M | $1M | $-8M | $-8M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-2M | · | · | $-9M | · | · | · |
Rentowność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -54600.0% | · | · | -29150.0% | -174200.0% | · | -199550.0% | · | · | -283.9% | · | |
| Net Margin | · | · | · | · | · | -53650.0% | · | · | -28225.0% | -168200.0% | · | -219325.0% | · | · | -304.1% | · | |
| EBITDA Margin | · | · | · | · | · | -54600.0% | · | · | -29150.0% | -174200.0% | · | -199550.0% | · | · | -283.9% | · | |
| ROA | -30.5% | -50.3% | · | -31.9% | -22.3% | -26.3% | · | -9.8% | -6.9% | -6.2% | -19.5% | -17.2% | -15.0% | · | -9.8% | -11.0% | |
| ROE | -44.1% | -85.8% | · | -41.9% | -28.3% | -36.6% | · | -13.6% | -8.9% | -9.8% | -36.8% | -28.4% | -25.6% | · | -17.6% | -15.5% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 1.6 | · | 2.9 | 3.5 | 1.0 | · | 4.3 | 5.2 | 4.9 | 2.8 | 3.7 | 2.2 | · | 1.7 | 2.3 | |
| Quick Ratio | 0.1 | 0.6 | · | 2.1 | 2.7 | 0.3 | · | 2.0 | 2.7 | 3.3 | 2.6 | 3.6 | 1.4 | · | 1.2 | 2.2 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.4 | · | 0.7 | 0.6 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | · | 0.0 | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -7.5 | -11.3 | · | -9.8 | -12.5 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | 0.0 | · | |
| Receivables Turnover | 0.0 | 0.0 | · | · | 0.0 | 1.3 | · | · | 1.0 | 2.0 | 0.0 | 2.0 | · | · | 1.3 | · |
Wycena (TTM) 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $2.0K | · | $2.0K | $6.0K | $7.0K | · | $5.0K | $9.0K | $5.0K | $3M | $3M | · | · | · | · | |
| Net Income TTM | $-4M | $-4M | · | $-4M | $-4M | $-5M | · | $-12M | $-20M | $-29M | $-36M | $-38M | $-39M | · | $-51M | $-65M | |
| Market Cap | $6M | $7M | · | $5M | $10M | $2M | · | $5M | $11M | $290M | $4.69B | $18.41B | $22.74B | · | $55.77B | $40.21B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | $286M | $4.68B | $18.39B | $22.73B | · | $55.76B | $40.17B | |
| P/E | -1.0 | -1.2 | · | -0.9 | -1.8 | -0.5 | · | -0.4 | -0.6 | -1.5 | -1.7 | -12.3 | -122.7 | · | -1032.0 | -581.2 | |
| P/S | · | 3401.1 | · | 2658.0 | 1677.1 | 336.3 | · | 1031.2 | 1245.4 | 57965.3 | 1609.7 | 6314.9 | · | · | · | · | |
| P/B | 8.6 | 5.3 | · | 1.9 | 2.7 | 2.2 | · | 1.9 | 3.0 | 60.4 | 337.6 | 850.3 | 770.6 | · | 1736.8 | 1000.7 | |
| P / Tangible Book | 8.6 | 5.3 | · | 1.9 | 2.7 | 2.2 | · | 1.9 | 3.0 | 60.4 | 337.6 | 850.3 | 770.6 | · | 1736.8 | 1000.7 | |
| P / Cash Flow | · | -6.6 | · | · | · | -3.0 | · | · | · | -151.2 | · | · | -2424.0 | · | · | · | |
| P / FCF | · | · | · | · | · | · | · | · | · | -151.2 | · | · | -2408.3 | · | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | -164.0 | -540.2 | -2303.9 | -2349.7 | · | -6747.3 | -4351.0 | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -149.0 | · | · | -2407.0 | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 57136.3 | 1605.6 | 6308.6 | · | · | · | · | |
| Earnings Yield | -96.5% | -85.3% | · | -105.8% | -55.9% | -212.9% | · | -241.0% | -179.3% | -68.9% | -58.8% | -8.1% | -0.81% | · | -0.10% | -0.17% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $5.0K | $10.0K | $5.0K | $3M | $398.0K |
| Marża Operacyjna % | — | — | -685340.0% | -1201.4% | -19484.7% |
| Zysk netto | $-4M | $-5M | $-5M | $-38M | $-79M |
| Rozwodniony EPS | $-2.20 | $-2.92 | $-21.97 | $-2.61 | $-0.37 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | — | — | 0.0 | 0.4 | 0.4 |
| Wskaźnik bieżący | — | — | 4.2 | 2.2 | 4.9 |
| Wskaźnik Szybkości | — | — | 3.1 | 1.6 | 4.8 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | — | — | $-30M | $-29M | $-65M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 35 emitentów · $202K łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 10 (+7 vs poprzedni kw.) | 4 (+2 vs poprzedni kw.) | 7 (+3 vs poprzedni kw.) | 1 (-3 vs poprzedni kw.) | -2K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $48 258 | 21 353 | 23,89% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $40 673 | 17 993 | 20,14% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $35 023 | 15 497 | 17,34% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $31 782 | 14 063 | 15,74% | Akcje |
| CITADEL ADVISORS LLC | $26 826 | 11 870 | 13,28% | Akcje |
| OSAIC HOLDINGS, INC. | $3 907 | 1 731 | 1,93% | Akcje |
| Tower Research Capital LLC (TRC) | $3 663 | 1 621 | 1,81% | Akcje |
| Arax Advisory Partners | $2 749 | 1 216 | 1,36% | Akcje |
| MORGAN STANLEY | $1 889 | 836 | 0,94% | Akcje |
| VANGUARD GROUP INC | $1 618 | 501 | 0,80% | Akcje |
| Vanguard Global Advisers, LLC | $1 132 | 501 | 0,56% | Akcje |
| ROYAL BANK OF CANADA | $1 000 | 375 | 0,50% | Akcje |
| WELLS FARGO & COMPANY/MN | $877 | 388 | 0,43% | Akcje |
| CIBC Private Wealth Group LLC | $723 | 300 | 0,36% | Akcje |
| Sugarloaf Wealth Management, LLC | $322 | 169 | 0,16% | Akcje |
| Blue Trust, Inc. | $305 | 135 | 0,15% | Akcje |
| Steward Partners Investment Advisory, LLC | $253 | 112 | 0,13% | Akcje |
| BOKF, NA | $149 | 66 | 0,07% | Akcje |
| Federation des caisses Desjardins du Quebec | $149 | 66 | 0,07% | Akcje |
| UBS Group AG | $108 | 48 | 0,05% | Akcje |
| Axiom Investment Management LLC | $104 | 46 | 0,05% | Akcje |
| MERCER GLOBAL ADVISORS INC /ADV | $86 | 38 | 0,04% | Akcje |
| Key Financial Inc | $54 | 24 | 0,03% | Akcje |
| SIGNATUREFD, LLC | $52 | 23 | 0,03% | Akcje |
| NFSG Corp | $47 | 21 | 0,02% | Akcje |
| LANARK FINANCIAL, INC. | $45 | 20 | 0,02% | Akcje |
| AdvisorNet Financial, Inc | $43 | 19 | 0,02% | Akcje |
| BARCLAYS PLC | $34 | 15 | 0,02% | Akcje |
| Sunbelt Securities, Inc. | $29 | 10 | 0,01% | Akcje |
| WEST PACES ADVISORS INC. | $23 | 10 | 0,01% | Akcje |
| CWM, LLC | $23 | 8 | 0,01% | Akcje |
| IFG Advisory, LLC | $14 | 6 | 0,01% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $14 | 6 | 0,01% | Akcje |
| Tidemark, LLC | $5 | 2 | 0,00% | Akcje |
| TUCKER ASSET MANAGEMENT LLC | $3 | 1 | 0,00% | Akcje |
Insiderzy spółki 46 insiderów · 22 dyrektorzy generalni · 26 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Dale Curtis Hogue Jr. | Chief Executive Officer, Interim | 29 marca 2025 A | — | 0 | 0 | $0 |
| Kevin S. Boyle Sr. | Chief Executive Officer | 1 września 2023 S | 798 236 | 0 | 0 | $0 |
| Laurence James Neil Cooper | President and CEO | 4 stycznia 2021 S | 1 799 280 | 0 | 0 | $0 |
| Jonathan Lewis | CEO | 31 grudnia 2014 A | 744 145 | 0 | 0 | $0 |
| Sath Shukla | EVP, Chief Financial Officer | 29 stycznia 2020 A | 80 500 | 0 | 0 | $0 |
| Jason Amello | Executive Vice President & CFO | 8 maja 2013 F | 22 377 | 0 | 0 | $0 |
| David M Mauney MD | President | 29 stycznia 2020 A | 275 778 | 0 | 0 | $0 |
| Hagop Youssoufian | President of R&D and CMO | 31 grudnia 2012 A | 92 721 | 0 | 0 | $0 |
| Richard E Bagley | President, COO & Treasurer | 31 grudnia 2011 F | 211 239 | 0 | 0 | $0 |
| Caesar J Belbel | COO, CLO, and Secretary | 31 grudnia 2017 F | 207 434 | 0 | 0 | $0 |
| Ferdinand Groenewald | Vice President of Finance | 18 sierpnia 2025 A | 10 775 | 0 | 0 | $0 |
| Melinda Lackey | Legal & Administration | 29 marca 2025 A | — | 0 | 0 | $0 |
| Abhishek K Srivastava | Vice President, Technical Operations | 15 marca 2023 A | — | 0 | 0 | $0 |
| Drew Deniger | Vice President, Research and Development | 15 marca 2023 A | — | 0 | 0 | $0 |
| Michael Wong | Vice President, Finance | 15 marca 2023 A | — | 0 | 0 | $0 |
| Eleanor De Groot | EVP, Operations | 30 marca 2022 A | 237 106 | 0 | 0 | $0 |
| Raffaele Baffa | Chief Medical Officer | 17 maja 2021 A | 280 645 | 0 | 0 | $0 |
| Jill Buck | EVP, GM Gene Therapy | 4 marca 2021 A | 231 016 | 0 | 0 | $0 |
| Robert Hadfield | Chief Legal Officer and Sec. | 4 marca 2021 A | 176 819 | 0 | 0 | $0 |
| Kevin G Lafond | SVP, Treasurer & CAO | 8 stycznia 2021 S | 63 965 | 0 | 0 | $0 |
| Francois Lebel | Executive Vice President R&D | 31 grudnia 2017 F | 200 566 | 0 | 0 | $0 |
| Robert Peter Gale | Senior V.P. of Research | 26 kwietnia 2006 A | — | 0 | 0 | $0 |
| Michael Allen Jerman | Dyrektor | 23 lipca 2026 A | 23 759 | 0 | 0 | $0 |
| Jaime Vieser | Dyrektor | 23 lipca 2026 A | 47 642 | 0 | 0 | $0 |
| Postma Robert W | Dyrektor | 23 lipca 2026 A | 58 609 | 0 | 0 | $0 |
| Robert Hofmeister | Dyrektor | 6 czerwca 2024 A | — | 0 | 0 | $0 |
| James Huang | Dyrektor | 6 czerwca 2023 A | 188 333 | 0 | 0 | $0 |
| Mary Thistle | Dyrektor | 6 czerwca 2023 A | 45 000 | 0 | 0 | $0 |
| Christopher Bowden | Dyrektor | 22 czerwca 2022 A | 44 167 | 0 | 0 | $0 |
| Heidi Hagen | Dyrektor | 2 września 2021 P | 145 889 | 0 | 0 | $0 |
| Kevin J Buchi | Dyrektor | 4 marca 2021 A | 4 167 | 0 | 0 | $0 |
| Scott Braunstein | Dyrektor | 31 grudnia 2019 A | 31 780 | 0 | 0 | $0 |
| Douglas W. Pagan | Dyrektor | 31 grudnia 2019 A | 35 943 | 0 | 0 | $0 |
| Elan Ezickson | Dyrektor | 31 grudnia 2019 F | 71 887 | 0 | 0 | $0 |
| Scott Tarriff | Dyrektor | 31 grudnia 2019 A | 4 186 | 0 | 0 | $0 |
| James Anthony Cannon | Dyrektor | 7 maja 2019 M | 398 050 | 0 | 0 | $0 |
| Murray Brennan | Dyrektor | 30 grudnia 2017 F | 72 620 | 0 | 0 | $0 |
| Wyche Fowler | Dyrektor | 30 grudnia 2017 F | 156 446 | 0 | 0 | $0 |
| Michael Weiser | Dyrektor | 30 grudnia 2017 F | 224 282 | 0 | 0 | $0 |
| RANDAL J. KIRK | Dyrektor | 31 sierpnia 2016 J | 122 309 | 0 | 0 | $0 |
| Timothy Mcinerney | Dyrektor | 31 grudnia 2014 F | 372 120 | 0 | 0 | $0 |
| George B Abercrombie | Dyrektor | 5 kwietnia 2010 A | 25 000 | 0 | 0 | $0 |
| Gary S Fragin | Dyrektor | 31 marca 2010 A | 67 500 | 0 | 0 | $0 |
| ESSEX WOODLANDS HEALTH VENTURES FUND VI L P | Posiadacz 10% | 8 grudnia 2009 P | 2 371 642 | 0 | 0 | $0 |
| Lindsay A. Rosenwald, M.D. | Posiadacz 10% | 3 maja 2006 J | — | 0 | 0 | $0 |
| Holger Weis | — | 6 sierpnia 2026 A | 25 483 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 11 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Price Adrian, Chris Butterworth, Richard Jones, Edward Jones, Gareth Downing, Richard Kotey, Chris Cole, Arif Chaudrey, Emma Babb, Colin Craig, John Nicholls, Carl Ware, Andrew Turner, Matthew Robbins, Phillip James Stead, Stephen Hennessy, Greg Arnold, Michelle Douglas, HexagonONE Ltd, Alimenta Holding Limited, Krakatau Holding Limited ×3 zgłoszenia | 5 marca 2026 | 8,60% | Aneks | — | SEC |
| Chris Butterworth, Richard Jones, Edward Jones, Gareth Downing, Richard Kotey, Chris Cole, Arif Chaudrey, Emma Babb, Colin Craig, John Nicholls, Carl Ware, Andrew Turner, Matthew Robbins, Phillip James Stead, Stephen Hennessy, Greg Arnold, Michelle Douglas, Price Adrian ×2 zgłoszenia | 31 października 2025 | 8,60% | Aneks | — | SEC |
| PMGC CAPITAL LLC, PMGC Holdings Inc. ×2 zgłoszenia | 5 września 2025 | 0,00% | Aneks | — | SEC |
| WaterMill Asset Management Corp., Postma Robert W | 1 lipca 2025 | 9,00% | Pierwotne zgłoszenie | — | SEC |
| RANDAL J. KIRK ×8 zgłoszenia | 12 grudnia 2018 | — | Pierwotne zgłoszenie | — | SEC |
| 15 października 2018 | — | Pierwotne zgłoszenie | — | SEC | |
| 6 lipca 2016 | — | Pierwotne zgłoszenie | — | SEC | |
| RANDAL KIRK | 9 czerwca 2015 | — | Pierwotne zgłoszenie | — | SEC |
| Millennium Partners, L.P., Millenco LLC, Millennium Management LLC, Israel A. Englander ×3 zgłoszenia | 18 czerwca 2009 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca, Niezgłoszona osoba raportująca | 27 września 2005 | — | Pierwotne zgłoszenie | — | SEC |
| Lindsay A. Rosenwald, M.D. | 23 września 2005 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 1 fundusz ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 14 063 SH | 8 sierpnia 2026 | Dziennie |